Retrospective analysis of patients’ experience to intravesical Bacillus Calmette-Guerin (BCG)

Alcorn, J.; Biyani, S.; Weston, S.; Sundaram, R.; Burton, Rob; Topping, Annie; Stephenson, John

Retrospective analysis of patients’ experience to intravesical Bacillus Calmette-Guerin (BCG)

Alcorn, J., Biyani, S., Weston, S., Sundaram, R., Burton, Rob, Topping, Annie and Stephenson, John (2015) Retrospective analysis of patients’ experience to intravesical Bacillus Calmette-Guerin (BCG). In: EAU 15: European Association of Urology, 20th-24th March 2015, Madrid, Spain.

[+][-]

Abstract

Why?
•
Gold standard
•
Bladder cancer incidence rates are highest in developed countries, especially Northern America and Europe
•
BCG treatment induction & maintenance has significant benefits, but also has significant side effects that tend to be seen within the first 12 months of treatment
•
To analyse the reasons for treatment interruption in everyday clinical practice in a large district hospital

Information

URI:

https://eprints.hud.ac.uk/id/eprint/23464

Title:

Retrospective analysis of patients’ experience to intravesical Bacillus Calmette-Guerin (BCG)

Creators:

Alcorn, J., Biyani, S., Weston, S., Sundaram, R., Burton, Rob, Topping, Annie and Stephenson, John

Date:

March 2015

Subjects:

R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RT Nursing

Schools: